Found: 259
Select item for more details and to access through your institution.
c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Impact of Pembrolizumab as a Salvage Therapy Based on HER2 Expression in Advanced Gastric Cancer.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2969, doi. 10.3390/cancers16172969
- By:
- Publication type:
- Article
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1624, doi. 10.1007/s10637-021-01078-6
- By:
- Publication type:
- Article
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 6, p. 782, doi. 10.1007/s10637-017-0463-y
- By:
- Publication type:
- Article
Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 6, p. 677, doi. 10.1007/s10637-016-0373-4
- By:
- Publication type:
- Article
Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 535, doi. 10.1007/s10637-014-0065-x
- By:
- Publication type:
- Article
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 561, doi. 10.1007/s10637-014-0075-8
- By:
- Publication type:
- Article
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 369, doi. 10.1007/s10637-013-0059-0
- By:
- Publication type:
- Article
Phase II trial of capecitabine and everolimus (RAD001) combination in refractory gastric cancer patients.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1580, doi. 10.1007/s10637-013-0022-0
- By:
- Publication type:
- Article
Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 6, p. 1602, doi. 10.1007/s10637-013-0028-7
- By:
- Publication type:
- Article
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 183, doi. 10.1007/s10637-012-9853-3
- By:
- Publication type:
- Article
Nilotinib in patients with metastatic melanoma harboring KIT gene aberration.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 5, p. 2008, doi. 10.1007/s10637-011-9763-9
- By:
- Publication type:
- Article
Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma.
- Published in:
- 2012
- By:
- Publication type:
- Report
Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1540, doi. 10.1007/s10637-011-9706-5
- By:
- Publication type:
- Article
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.
- Published in:
- European Radiology, 2022, v. 32, n. 1, p. 1, doi. 10.1007/s00330-021-08094-3
- By:
- Publication type:
- Article
Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 6, p. 446, doi. 10.1002/ajh.20874
- By:
- Publication type:
- Article
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer.
- Published in:
- Scientific Reports, 2014, p. 7592, doi. 10.1038/srep07592
- By:
- Publication type:
- Article
Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic Profiling.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep03623
- By:
- Publication type:
- Article
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction of Pazopanib-Based Treatment Response.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 2, p. 671, doi. 10.4143/crt.2022.251
- By:
- Publication type:
- Article
A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 189, doi. 10.4143/crt.2021.1527
- By:
- Publication type:
- Article
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1240, doi. 10.4143/crt.2021.1194
- By:
- Publication type:
- Article
Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 3, p. 894, doi. 10.4143/crt.2021.854
- By:
- Publication type:
- Article
A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1153, doi. 10.4143/crt.2020.173
- By:
- Publication type:
- Article
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 1128, doi. 10.4143/crt.2018.379
- By:
- Publication type:
- Article
Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node–Positive Gastric Cancer Treated with Different Adjuvant Protocols.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 876, doi. 10.4143/crt.2018.401
- By:
- Publication type:
- Article
Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 211, doi. 10.4143/crt.2018.132
- By:
- Publication type:
- Article
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 1, p. 44, doi. 10.4143/crt.2016.024
- By:
- Publication type:
- Article
A Retrospective Analysis for Patients with HER2-Positive Gastric Cancer Who Were Treated with Trastuzumab-Based Chemotherapy: In the Perspectives of Ethnicity and Histology.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 553, doi. 10.4143/crt.2015.155
- By:
- Publication type:
- Article
The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 153, doi. 10.4143/crt.2014.183
- By:
- Publication type:
- Article
Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 4, p. 738, doi. 10.4143/crt.2014.224
- By:
- Publication type:
- Article
Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 1, p. 72, doi. 10.4143/crt.2013.172
- By:
- Publication type:
- Article
Nomogram to Predict Treatment Outcome of Fluoropyrimidine/ Platinum-Based Chemotherapy in Metastatic Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 4, p. 285, doi. 10.4143/crt.2013.45.4.285
- By:
- Publication type:
- Article
Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2013, v. 45, n. 1, p. 22, doi. 10.4143/crt.2013.45.1.22
- By:
- Publication type:
- Article
Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.
- Published in:
- BMC Medical Genomics, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1755-8794-7-2
- By:
- Publication type:
- Article
A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2016, v. 20, n. 4, p. 375, doi. 10.1007/s40291-016-0205-4
- By:
- Publication type:
- Article
Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial).
- Published in:
- Journal of Cancer Research & Therapeutics, 2024, v. 20, n. 3, p. 972, doi. 10.4103/jcrt.jcrt_2698_22
- By:
- Publication type:
- Article
Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
- Published in:
- Journal of Cancer Research & Therapeutics, 2021, v. 17, n. 4, p. 1047, doi. 10.4103/jcrt.JCRT_108_19
- By:
- Publication type:
- Article
Analysis of intrapatient heterogeneity of circulating tumor cells at the single-cell level in the cerebrospinal fluid of a patient with metastatic gastric cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cover Image, Volume 119, Number 12, December 2022.
- Published in:
- Biotechnology & Bioengineering, 2022, v. 119, n. 12, p. i, doi. 10.1002/bit.28287
- By:
- Publication type:
- Article
All‐in‐one microfluidic design to integrate vascularized tumor spheroid into high‐throughput platform.
- Published in:
- Biotechnology & Bioengineering, 2022, v. 119, n. 12, p. 3678, doi. 10.1002/bit.28221
- By:
- Publication type:
- Article
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 9, p. 1532, doi. 10.1038/mt.2015.109
- By:
- Publication type:
- Article
Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-41098-0
- By:
- Publication type:
- Article
Computational measurement of tumor immune microenvironment in gastric adenocarcinomas.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32299-0
- By:
- Publication type:
- Article
Prevalence and detection of low-allele-fraction variants in clinical cancer samples.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01470-y
- By:
- Publication type:
- Article
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
- Published in:
- Genome Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13073-021-00995-8
- By:
- Publication type:
- Article
Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00826-w
- By:
- Publication type:
- Article
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00776-9
- By:
- Publication type:
- Article